Baolingbao Biology Co Ltd (002286) — Cash Flow Reinvestment Rate
Baolingbao Biology Co Ltd (002286) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥42.30 Million (capex CN¥42.30 Million ) from operating cash flow of CN¥134.96 Million. See 002286 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Baolingbao Biology Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Baolingbao Biology Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 002286 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Baolingbao Biology Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Baolingbao Biology Co Ltd. See 002286 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.06x | CN¥274.80 Million | CN¥259.36 Million | CN¥189.30 Million | ▲ +19.5% |
| 2024 | 0.89x | CN¥220.53 Million | CN¥248.72 Million | CN¥189.93 Million | ▼ -16.7% |
| 2023 | 1.06x | CN¥300.33 Million | CN¥282.28 Million | CN¥152.23 Million | ▼ -91.2% |
| 2022 | 12.14x | CN¥374.04 Million | CN¥30.82 Million | CN¥254.55 Million | ▲ +1199.7% |
| 2021 | 0.93x | CN¥192.60 Million | CN¥206.27 Million | CN¥92.85 Million | ▲ +162.0% |
| 2020 | 0.36x | CN¥141.98 Million | CN¥398.46 Million | CN¥131.93 Million | ▼ -61.5% |
| 2019 | 0.92x | CN¥142.40 Million | CN¥153.95 Million | CN¥95.46 Million | ▼ -57.5% |
| 2018 | 2.17x | CN¥289.31 Million | CN¥133.05 Million | CN¥173.71 Million | ▲ +117.8% |
| 2016 | 1.00x | CN¥108.81 Million | CN¥108.98 Million | CN¥96.53 Million | ▼ -81.7% |
| 2015 | 5.46x | CN¥422.83 Million | CN¥77.49 Million | CN¥199.40 Million | ▲ +103.5% |
| 2014 | 2.68x | CN¥272.91 Million | CN¥101.77 Million | CN¥272.91 Million | ▲ +55.7% |
| 2013 | 1.72x | CN¥147.47 Million | CN¥85.60 Million | CN¥147.47 Million | ▲ +140.3% |
| 2012 | 0.72x | CN¥67.50 Million | CN¥94.15 Million | CN¥67.50 Million | ▼ -7.0% |
| 2011 | 0.77x | CN¥132.31 Million | CN¥171.70 Million | CN¥132.31 Million | ▼ -86.8% |
| 2010 | 5.86x | CN¥160.82 Million | CN¥27.45 Million | CN¥160.82 Million | ▲ +178.9% |
| 2009 | 2.10x | CN¥93.51 Million | CN¥44.51 Million | CN¥93.51 Million | ▲ +234.8% |
| 2008 | 0.63x | CN¥69.51 Million | CN¥110.77 Million | CN¥69.51 Million | ▼ -78.6% |
| 2007 | 2.93x | CN¥231.69 Million | CN¥78.98 Million | CN¥231.69 Million | ▲ +285.3% |
| 2006 | 0.76x | CN¥14.56 Million | CN¥19.12 Million | CN¥14.56 Million | — |